Vericel Corp. (NASDAQ:VCEL) saw an uptick in trading volume on Friday . 291,218 shares were traded during trading, an increase of 97% from the previous session’s volume of 147,534 shares.The stock last traded at $2.26 and had previously closed at $2.19.

The stock’s 50-day moving average is $2.19 and its 200 day moving average is $2.78. The firm’s market cap is $48.23 million.

Vericel Corp. (NASDAQ:VCEL) last posted its earnings results on Monday, August 8th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.16) by $0.05. The business had revenue of $12.80 million for the quarter, compared to the consensus estimate of $15.05 million. On average, equities research analysts predict that Vericel Corp. will post ($0.91) EPS for the current year.

Vericel Corporation, formerly Aastrom Biosciences, Inc, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.